Pharma Foods International Co., Ltd. provided consolidated earnings guidance for the year ending July 31, 2022. For the period, the company expects net sales of ¥60,900 million, operating profit of ¥3 million, and a loss attributable to owners of the parent of ¥1,500 million or ¥51.71 per share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
877 JPY | +0.57% | -0.45% | -12.48% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.48% | 158M | |
+33.93% | 50.85B | |
+0.26% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.74% | 26.11B | |
-22.16% | 19.13B | |
+8.67% | 13.05B | |
+27.06% | 12.16B | |
+24.38% | 12.08B |
- Stock Market
- Equities
- 2929 Stock
- News Pharma Foods International Co., Ltd.
- Pharma Foods International Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending July 31, 2022